Megna Michael R (CIK 1464583) reported 43 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-13). Recent activity: Sell KNSA (6,625 shares), Buy KNSA (3,932 shares), Sell KNSA (1,666 shares), Buy KNSA (372 shares), Buy KNSA (7,564 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-13 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 6,625 | $309,321 |
| 2026-04-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 3,932 | $3,932 |
| 2026-04-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 1,666 | $81,534 |
| 2026-04-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 372 | $8,988 |
| 2026-04-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 7,564 | $0 |
| 2026-04-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 3,205 | $154,257 |
| 2025-10-22 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 13,235 | $520,268 |
| 2025-10-22 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 6,195 | $80,349 |
| 2025-10-22 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 9,831 | $109,124 |
| 2025-10-22 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 9,831 | $117,677 |
| 2025-10-22 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 12,787 | $137,588 |
| 2025-10-22 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 37,255 | $1.4M |
| 2025-10-22 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 791 | $12,260 |
| 2025-10-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 175 | $0 |
| 2025-10-08 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 85 | $3,272 |
| 2025-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 2,363 | $0 |
| 2025-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 2,557 | $0 |
| 2025-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 3,933 | $0 |
| 2025-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 4,282 | $143,404 |
| 2025-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 774 | $0 |
| 2025-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 375 | $12,855 |
| 2025-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 11,000 | $197,120 |
| 2025-09-03 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Sell | 11,000 | $383,240 |
| 2025-08-06 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 495 | $7,737 |
| 2025-08-06 | Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF ACCOUNTING OFFICER | Buy | 17,000 | $263,840 |
Source: SEC Form 4 filings · as of 2026-04-13